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Objective: To establish the inﬂuence of clinical status at diagnosis and of gender on progression of HIV/
AIDS determined by clinical-biological factors in patients from Cordoba City (Argentina) from 1995 to
2005).
Methods: Gender and clinical and laboratory data were evaluated by descriptive statistics, non-parametric
survival analysis, and generalized linear models at the beginning of the study (diagnosis) and at the end
(hospital records, n=209).
Results: At diagnosis, women (n=28, 13.4%) had a higher probability of being asymptomatic than men
(n=181, 86.6%). High viremia was associated with advanced clinical stages, but was inversely related to
CD4 count. Truncated Kaplan-Meier curves were similar for both sexes. The probability of not having AIDS
criteria at the end of the study was higher in patients without these criteria at diagnosis. Women had a
higher probability of having AIDS at the end of the follow-up than men. In contrast, men had a higher
prevalence of venereal diseases (n=38, 21%), dysmetabolic proﬁle (n=14, 7.7%) and positive serology for
opportunists (n=31, 17.1%). Marker diseases were mainly represented by internal mycosis and waste
syndrome, although less speciﬁc ﬁndings (anemia, oral lesions) were also associated with progression.
Conclusions: Using an integrative approach, high viremia was critically linked to clinical and lymphocyte
impairment. Early diagnosis was a major determinant of clinical course, with women having a worse
prognosis. However, men were diagnosed in clinically advanced stages and with other non-HIV-related
entities, which could affect progression. These ﬁndings should be integrated into the planning of
preventive strategies.
& 2008 SESPAS. Published by Elsevier Espan˜a, S.L. All rights reserved.Condicionamiento de la evolucio´n del VIH/sida deﬁnida por criterios clı´nico-
biolo´gicos en adultos de la ciudad de Co´rdoba (Argentina), de 1995 a 2005, por
la brecha sanitaria existente entre ambos sexosPalabras clave:
Sida
VIH
Sexo
Evolucio´n del pacienteR E S U M E N
Objetivos: Establecer la inﬂuencia de la condicio´n me´dica al diagno´stico y del sexo en la evolucio´n del
VIH/Sida determinada por factores clı´nico-biolo´gicos en pacientes de la ciudad de Co´rdoba (Argentina,
1995–2005).
Me´todos: El sexo, los datos clı´nicos y los de laboratorio fueron evaluados por estadı´stica descriptiva,
ana´lisis de supervivencia no parame´trico y modelos lineales generalizados al inicio (diagno´stico) y al ﬁnal
del estudio (registro hospitalario, 209 casos).
Resultados: Las mujeres (n=28, 13,4%) tienen mayor probabilidad de estar asintoma´ticas que los hombres
(n=181, 86,6%) en el momento del diagno´stico. La viremia alta esta´ asociada con estadios clı´nicos
avanzados, pero esta´ inversamente relacionada con el de CD4. Las curvas truncadas de Kaplan-Meier son
similares para ambos sexos. La probabilidad de no tener criterios de sida al ﬁnal del estudio esta´
incrementada para los pacientes diagnosticados sin ellos. Adema´s, las mujeres tienen mayor probabilidad
de presentar sida que los hombres al ﬁnalizar el seguimiento recuento. No obstante, ellos mostraron una
elevada prevalencia de enfermedades vene´reas (n=38, 21%), perﬁl dismetabo´lico (n=14, 7,7%) y serologı´a
para oportunistas (n=31, 17,1%). Las enfermedades marcadoras fueron principalmente micosis internas y
sı´ndrome consuntivo, aunque hallazgos menos especı´ﬁcos (anemia, lesiones orales) tambie´n se asociaban a
la progresio´n.
Conclusiones: Utilizando un enfoque integrador, la viremia estuvo muy ligada al empeoramiento clı´nico y
linfocitario, siendo el diagno´stico temprano un determinante mayor de evolucio´n, con las mujeres teniendo
peor prono´stico. Sin embargo, los hombres fueron diagnosticados avanzados clı´nicamente, con otros
problemas no asociados al VIH que podrı´an afectar su evolucio´n. Estos resultados deberı´an ser integrados
en el planeamiento sanitario de prevencio´n.
& 2008 SESPAS. Publicado por Elsevier Espan˜a, S.L. Todos los derechos reservados.shed by Elsevier Espan˜a, S.L. All rights reserved.
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The illness caused by the human immunodeﬁciency virus
(HIV) has a chronic progression. It starts with an acute syndrome
and serological conversion, and is then followed by a long-term
phase of clinical latency. Ultimately, AIDS-related complex and
acquired immunodeﬁciency syndrome (AIDS) constitute the ﬁnal
stage. The virus replicates continuously into CD4-positive lym-
phocytes, thereby causing their depletion. Since these cells are a
critical point for adaptive immunity, the infection predisposes to
opportunistic infections and malignancies (opportunists/oppor-
tunism: diseases which appear only with immunocompromise).1
UNAIDS has estimated that at least 40 million people live with
HIV/AIDS, with 3 million deaths and 5 million new cases every
year. The number of HIV/AIDS cases notiﬁed in Argentina since
2001, when the obligatory notiﬁcation began, was 34,803 with a
male prevalence. The majority of people living with this infection
reside in Capital Federal (30%), Buenos Aires (30%), Cordoba (6%)
and Santa Fe (4%). In the year 2005, Argentina exhibited rates of
12.9 HIV cases and of 4.3 AIDS cases per 100,000 persons, which
have tended to decrease since the year 1997, when HAART was
introduced. Regarding Cordoba, the rate of HIV cases per 100,000
persons was 11.6 in 2005. The most relevant transmission way
was sexual (82% of women and 73% of men, of which 31%
corresponded to homosexual practice). Also, 4.6% of women and
14.5% of men used injected drugs. The 4.3% of the cases were due
to vertical transmission.2
The epidemiological characterization of the infection is
difﬁcult due to its varying spread patterns in different regions
worldwide.3 Consequently, infection behaviour should be ana-
lyzed thoroughly in each population in the context of the general
pandemic reality.4 Furthermore, the integration of different
statistical methods is necessary, so that reliable tools may be
obtained for medical decision mechanisms. Patient surveys
should be realized by medical institutions in order to improve
engagement and retention in care, and to achieve an organiza-
tional self-assessment to effect operational changes that minimize
barriers to care.5 Subsequently, this study uses an integral trend
of HIV/AIDS in an Argentinean city, and its purpose is to establish
the role of the diagnostic condition and the gender inﬂuence in
this infection by establishing the close relationship between
medical status at diagnosis and during evolution, by means of
analysis of the clinical and biological markers of the HIV infection.Methods
Subjects and setting
Data were collected from hospital records (Hospital Nacional
de Clı´nicas, Universidad Nacional de Co´rdoba) anonymously in
agreement with ethical concerns for 209 adult patients from the
Cordoba City (Argentina) in the period 1995–2005. Non experi-
mental procedures were performed for this prospecting work
made in retrospect, with a sample under current medical control
being described.
Patients were classiﬁed according to the Control Disease
Center criteria, regarding the peripheral blood CD4 count (1:
4500, 2: 200–499, 3: o200 CD4 cells/ml), plasmatic viral load
(o or 4100 000 copies/mL-VL-) and clinical categories (A: health
or non-related diseases; B: related diseases; C: marker diseases,
opportunism).6 Asymptomatic people were tested in regard to
antecedents of risk behaviours. Patients who exhibited o200-
CD4, 4105-VL and/or opportunistic pathologies were obligatorily
treated with antiretroviral drugs. Individuals who presented
AIDS criteria (clinical category C and/or level 3 of CD4) at thediagnostic instance were considered lately-diagnosed patients.
The transmission ways were in accordance with governmental
data.2
Laboratory
CD4 and VL were assayed by ﬂow cytometry and RT-PCR,
respectively.7,8 Other biochemical probes had been performed
using standard commercial kits, provided by Wiener Lab (Argen-
tina).
Statistical analysis
Results are expressed as mean (SD). Clinical-biological records
were studied during diagnosis and progression, with the descrip-
tive analyses examining the prevalence of clinical and biochem-
ical parameters. Data recorded at the time of serological
conﬁrmation were analyzed by two different approaches. First,
the clinical stage was considered as the response variable, and a
proportional odds model was ﬁtted,9 with gender and VL factors
as covariates in the linear predictor. Then, the association
between CD4, gender and VL was assessed using a log-linear
model for ordinal data.10 In the construction of the interaction
terms, this association model considers scores for the three
ordered CD4 categories.
The incidence rate of opportunism was calculated for each
gender, assuming that individual times could vary (IR=new cases
of opportunism/S individual times free of opportunism).11
Also, using the appearance of marker diseases (opportunism)
as the clinical evolution indicator, the cumulative probability
was estimated for time free of these by the Kaplan-Meier
method,12 with gender differences being investigated by the
log-rank test.13
Finally, the association between the initial and ﬁnal medical
status, i.e. at the diagnosis and at the end of the study, was
analyzed by log-linear models,10 with patients being classiﬁed
according to sex and presence/absence of AIDS criteria, at each
instance. This categorization of initial and ﬁnal stages avoids
treatment being a confounding factor, since treatment was strictly
given to every patient diagnosed with AIDS. Newly diagnosed
patients (o1 evolution year) were excluded, since they did not
have enough time to change the category.
The signiﬁcance level used was a=0.05. Data were analyzed
using InfoStat2007e.1 (InfoStat Group, http://www.infostat.co-
m.ar) and R version 2.0.1 (R Development Core Team, http://
www.R-project.org).Results
181 men (86.6%) were of mean age 35.278.7 (range=18–66),
and 28 women (13.4%) were 38.1710.4 (range=20–61). This
included 15% men and 25% women who had been recently
diagnosed (o1 year from the diagnosis). Patients were enrolled at
27.1171.84 (men) and 4.7872.34 (women) individuals per year,
involving mainly the 24–42 year-old range at different clinical
stages (table 1).
Diagnosis
71.8% men presented stage A. Nonetheless, 37.6% had other
negative medical conditions (not speciﬁcally related to AIDS),
including abnormal laboratory tests. These laboratory ﬁndings
were: sustained high IgG in mononucleosis-like syndromes
(Toxoplasma spp., cytomegalovirus, Epstein-Barr virus) (n=31),
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Table 1
Clinical-epidemiological proﬁle of the studied sample
A. Demographic compositiona
Age ranges Men (n=181) Women (n=28)
[18;24) 9 (5.0%) 2 (7.1%)
[24;30) 37 (20.4%) 3 (10.7%)
[30;36) 60 (33.1%) 8 (28.6%)
[36;42) 44 (24.3%) 5 (17.9%)
[42;48) 13 (7.2%) 4 (14.3%)
[48;54) 9 (5.0%) 4 (14.3%)
[54;60) 5 (2.8%) 1 (3.6%)
[60;66] 4 (2.2%) 1 (3.6%)
B. Diagnostic medical status
according to the viral load (copies/ml)
CDC stagesb Men (n=181) Women (n=28)
o105 (n=136) 4105 (n=45) o105 (n=18) 4105 (n=10)
A1 72 (53.0%) 9 (20.0%) 6 (33.3%) 2 (20.0%)
A2 40 (29.4%) 6 (13.3%) 10 (55.6%) 2 (20.0%)
A3 2 (1.5%) 1 (2.2%) 2 (11.1%) 2 (20.0%)
B1 10 (7.4%) 2 (4.5%) 0 (0.0%) 0 (0.0%)
B2 3 (2.2%) 4 (8.9%) 0 (0.0%) 1 (10.0%)
B3 1 (0.7%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
C1 1 (0.7%) 1 (2.2%) 0 (0.0%) 0 (0.0%)
C2 1 (0.7%) 2 (4.5%) 0 (0.0%) 2 (20.0%)
C3 6 (4.4%) 20 (44.4%) 0 (0.0%) 1 (10.0%)
a Clinical records from the Hospital Nacional de Clı´nicas of Co´rdoba, Argentina (year 2005).
b Classiﬁcation from Control Disease Centers (CDC), USA.
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Fig. 1. Kaplan-Meier curves for clinical evolution of HIV infection: The curves
represent the cumulative probability of being free of opportunism (clinical stages
A and B) up to a determined time. References: men are in black and women are in
grey.
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sustained high IgG for other pathogens (Trypanosoma cruzi,
hepatitis B and A viruses) (n=4), among others (n=5). Other
sexually transmitted diseases were present in 21% of patients
(early syphilis: 18, chronic hepatitis: 13, papilloma virus: 5,
genital herpes simplex: 2, molluscum contagiosum: 1). There
were 7 cases of acute retroviral syndrome, with stage B being
principally represented by polymyositis, oral candidiasis, herpes
zoster, leucopoenia and thrombocytopenia. Anaemia was also a
common ﬁnding in progressing patients (n=2, B1; n=1, C2; n=10,
C3). Oral lesions were found in 16 persons, 13 with AIDS,
corresponding to oropharynx candidiasis and oral hairy leuko-
plakia. When CD4 decreased, seborrheic dermatitis, acute re-
spiratory infections, Kaposi’s sarcoma and waste syndrome
emerged. Pulmonary pneumocystosis (n=11), oesophagic candi-
diasis (n=4), disseminated histoplasmosis (n=2), progressive
multifocal leukoencephalopathy (n=2) and retinitis by cytome-
galovirus (n=1) conformed the marker illnesses. Other advanced
clinical events were chronic diarrhoea, fever of an unknown
origin, severe thrombocytopenia, peripheral neuropathy and
persistent generalized pruritus, all without a clear etiological
diagnosis. Pulmonary tuberculosis complicated with meningitis
was also found.
85.7% women were diagnosed as being asymptomatic, with
14.3% being detected during routine serological control in
obstetric patients. Also, oropharynx candidiasis was identiﬁed in
a B2 case. The rest were considered as AIDS cases, presenting
consumption with anaemia and oral hairy leukoplakia, herpes
zoster, pulmonary pneumocystosis, cerebral toxoplasmosis, me-
ningoencephalitis by Cryptococcus, persistent polyadenopathy and
neutropenia.
The proportional odds model (deviance=4.958, df=4, p=0.292)
showed that women have higher odds (4.13 times) of presenting a
better clinical condition than men (p=0.023), for a ﬁxed VL. The
odds of having an advanced clinical stage are higher (12.41 times)
for VL 4100,000 copies/mL (po0.001) for a given gender.
Furthermore, the association log-linear model was suitable forCD4 (deviance=8.71, df=5, p=0.121) showing that the CD4 is
inversely related to VL (po0.001), but is not associated to gender
(p=0.099).Evolution
The mean follow-up time was around four years (range:
o1–10 years). For both genders, 10 opportunistic cases occurred
per 100 person-years of follow-up, with about 1.6 episodes
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Table 2
Initial (diagnosis) and ﬁnal (end of study) medical statusa
Final
Men (n=154) Women (n=21)
HIV+b AIDS HIV + AIDS
Initial HIV + 115 (74.7%) 7 (4.5%) 11 (52.4%) 3 (14.3%)
AIDS 21 (13.6%) 11 (7.1%) 2 (9.5%) 5 (23.8%)
a Patients witho1 year of evolution (newly diagnosed individuals were not
included due to the insufﬁcient time to change their medical status).
b HIV positive patients without AIDS criteria.
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Kaplan-Meier, depicted in ﬁgure. 1, did not show any differences
between genders (X2=0.163, df=1, p=0.686). Data from 31 men and 2
women (17% vs. 7%) were considered as truncated, since they
were diagnosed already ill.
Regarding medical re-stratiﬁcation (deviance=0.005, df=2,
p=1) described in the Table 2, the odds of not having AIDS
criteria when the follow-up ﬁnishes are higher for patients (8.76
times) being diagnosed without AIDS (po0.001), for a given
gender. Also, women have higher odds (4.65 times) of presenting
AIDS at the end of the study than men (p=0.003), given an initial
condition.Discussion
The HIV/AIDS management involves early detection and close
evolutive monitoring, with epidemiological studies in developing
countries being imperative to support sanitary strategies.14 In the
present work, although many patients were at stage A, a several
advanced cases were still found. Moreover, the deleterious effect
of VL on CD4 and the clinical condition could be seen from the
point of diagnosis. Despite the fact that gender did not affect the
CD4, men had a greater possibility than women of being clinically
impaired at the time of diagnosis. Consequently, early detection
should be strongly encouraged to improve prognosis and infection
control,15 especially in male individuals, considering that preven-
tion messages are not being performed appropriately.16 Among
initial ﬁndings, the common occurrence of venereal diseases in
the males accounted for both behavioural and pathological
indicators, which could be preliminary motives for consulting.17
The clinical and laboratory prevalence for opportunistic infections
and/or debilitating conditions justiﬁed that their screening
included the asymptomatic patients. Chagas disease deserves
special attention, although it is not distributed worldwide, but it
depends on the immune status,18 with geographic variations of
tropical endemic infections being often not considered.19 During
successive medical appointments, hemogram alterations were
commonly found, especially anaemia, whose frequency increased
as infection progressed. Oral lesions exhibited the same behaviour
with regard to progression, as also did seborrhoea, respiratory
infections and Kaposi sarcoma, with these being related to
decreasing levels of CD4. Due to the relevance of oral lesions,
often sub-diagnosed and/or inadequately treated, buccal evalua-
tion is encouraged.20 Another problem linked to low CD4 was the
waste syndrome (principal marker disease together with pneu-
mocystosis), followed by other disseminated mycosis and neuro-
logical affections. Nonetheless, it is necessary to bear in mind that
opportunistic diseases are not reciprocally excluding, and that
other problems with an unclear etiopathology can also appear.
Different statistical models were applied, since the incidence
measures only give summary information. The Kaplan-Meiermethod allowed evolution to be studied, by taking marker
diseases as the progression criteria, although no differences
between genders were found. However, initially ill people were
not considered, thus causing a different data truncation for each
one. Indeed, the initial clinical status is relevant for gender
comparisons and infection management.21 For categorical data,
generalized linear models give a complete description about
associations, with increased power for detecting them.22
In the analysis of medical re-stratiﬁcation, it was conﬁrmed
that an early diagnosis was important in patient prognosis, since
individuals without initial AIDS criteria tended to stay in this
situation at the end of the study. Regarding gender, under the
mentioned methodological conditions (analyzing the HIV/AIDS
evolution in an alive population under sanitary control), female
evolution exhibits a worse prognosis than men, which will imply
further studies in order to develop complementary medical
actions to modulate their pathological progression. There is
ongoing debate concerning a potential gender effect. Several
factors may be involved in this response, although a previous
work established that no differences between sexes existed
respect to antiretroviral therapy.23 In the same research, low
patient adherence and presence of pharmacological toxicity
(evaluated in a speciﬁc subgroup under treatment) were the
main determinants of therapeutic failure. However, in another
work, women beneﬁted less from care, even though they were
admitted at earlier stages and offered standardized therapies with
unclear reasons, requiring further studies.24 In addition, the CD4
predicting value for speciﬁc sociodemographic groups is dis-
cussed,25 with VL having higher prognostic strength.26
Concerning the promotion of norms regarding risk reduction,
the peer education and gender-speciﬁc HIV prevention interven-
tions may be useful.27 In this sense, interventions seeking to
promote gender equity and to reduce HIV/STI may be more
effective when the socioeconomic context of gender ideologies is
assessed and addressed.28 HIV prevention programs should be
designed to increase knowledge about HIV transmission, treat-
ment, prevention and personal risk of contraction as well as
correct misconceptions about individuals with HIV or AIDS and
promote sex communication among partners. Since gender-
related behaviours have been proposed as risk determinants, the
measures of relational attitudes and experiences become relevant
to characterize sexual risk, especially among men.29
The proper evaluation of HIV urban behaviour should be
focused for different populations, since it allows developing
accurate health policies. Also, the integration of analytical tests
may enhance the outcomes’ value. Overall, an integrative
assessment, which studies of clinical-biological factors by differ-
ent methodologies, allows the close relationship between diag-
nostic stages and progression to be accomplished, in the
polymorphic long-term HIV infection.
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